Press Release FeedGet the RSS feed
Menu

Browse press releases

The newest releases come first, each with its full text here and a link to its original. Try the filters to narrow them down.

1,719 resultsPage 68 of 144, newest first
  1. AIOnco360® Has Been Selected as a National Pharmacy Partner for ETCAMAH™ (camizestrant)Onco360®, the nation’s leading independent Specialty Pharmacy, has been selected as a national pharmacy partner by AstraZeneca for Etcamah™ (camizestrant), which is indicated for the treatment of adult patients with hormone receptor (HR)-positive, HER2-negative, locally advanced or metastatic breast cancer upon detection of ESR1 mutation during aromatase inhibitor (AI) and CDK4/6 inhibitor therapy, based on a US Food and Drug Administration (FDA)-authorized test.1
  2. HealthcareBetterLife Pharma Inc.BetterLife Pharma Inc. Announces Closing of US$100 Million Public Offering of Common Shares and Pre-Funded WarrantsBetterLife Pharma Inc. (CSE: BETR) ("BetterLife" or the "Company"), a biotechnology company developing treatments for neurological disorders, is pleased to announce that it has closed its previously announced public offering (the "Offering") of common shares of the Company ("Common Shares") and pre-funded common share purchase warrants of the Company ("Pre-Funded Warrants" and, together with the Common Shares, the...
  3. FinanceLisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private PlacementCombined company to focus on developing first-in-class next-generation medicines for cardioendocrine diseases
  4. AIBayer to Present How it Rebuilt Global Planning with OMP at Gartner Supply Chain Planning Summit 2026Companies: BayerANTWERPEN, BELGIUM, Sept 17, 2026 - OMP, a leading provider of supply chain planning solutions, invites attendees of the Gartner Supply Chain Planning Summit 2026 in London to its joint session with multinational Bayer. Representatives of the Pharmaceutical division and the global IT department will show what it took to rebuild global planning around faster, higher-quality decisions, how Unison Planning™ supports that at scale, and where AI fits in. Rebuilding planning at Bayer's scale Bayer treated its move to Unison Planning™ as more than a system replacement, rebuilding processes, master data, and ways of working across its global manufacturing and affiliate network. During their Gartner session, Mirja Meyer, Principal Product Manager and Program Lead IT at Bayer, and Karsten Hahm, Program Lead OMP Implementation at Bayer Pharmaceuticals, will cover: What adoption actually took What changed in decision speed and quality Where AI fits on the roadmap ahead Sign up for the session Why planning leaders should attend AI-driven planning is on every agenda. Bayer's session addresses the part that usually goes unsaid: what a planning organization needs in place before an AI implementation survives the test of a real supply chain. Meet OMP and explore what it means to make decisions at the speed of change Throughout the Gartner Supply Chain Planning Summit (Oct 5-6, London), OMP is present at booth 203, demonstrating how Unison Planning™ and UnisonIQ help organizations move toward always-on supply chain orchestration. See how integrated planning, enhanced by the latest AI advancements, drives faster scenario evaluation, stronger collaboration, and measurable business results. Join OMP at Gartner to hear Bayer's journey firsthand and leave with a clearer path to faster, more confident supply chain decisions. Session at a glance Title: Inside Bayer's Global Planning Rebuild and AI Roadmap - Faster Decisions at Scale Speakers: Mirja Meyer, Principal Product Manager, Program Lead IT, Bayer Karsten Hahm, Program Lead OMP Implementation, Bayer Pharmaceuticals When: Tuesday, October 6, 11:15 - 11:45 AM GMT+1 / 12:15 - 12:45 PM CEST Where: InterContinental London - The O2, London, United Kingdom To see where you can meet OMP next, visit our events calendar. About OMP OMP helps companies facing complex planning challenges to excel, grow, and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries - spanning consumer goods, life sciences, chemicals, metals, paper, packaging, plastics, tires, and building products - benefit from using OMP's unique Unison Planning™. Solution and product inquiries Contact OMP +32 3 650 22 11 Media inquiries Kira Perdue (Carabiner) SOURCE: OMP
  5. FinanceSkyhawk Therapeutics annonce les résultats finaux à quinze mois de l'essai clinique de phase 1/2 du SKY-0515 chez des patients atteints de la maladie de HuntingtonL'ensemble de données portant sur une période de quinze mois correspond à l'analyse finale de l'étude de phase 1/2 Au point d'évaluation principal du 15ᵉ mois, les patients traités par SKY-0515 présentaient une différence de +1,59 point dans l'évolution de l'échelle composite unifiée...
  6. HealthcareShane Schaffer, Cingulate Chairman & CEO to Present “SMART Launch” Approach at Indegene Digital Summit: Rethinking Commercialization for Emerging PharmaChief Commercial Officer Bryan Downey Joins Panel Discussion on Reinventing the Launch Playbook for Small and Mid-Size Pharma
  7. HealthcareMatisse Pharmaceuticals closed Series A financing round to advance isupartob sodium through phase 2 clinical developmentMatisse Pharmaceuticals B.V., developing isupartob sodium for the treatment of sepsis, today announced the successful completion of a Series A round.
  8. FinanceArtiva Biotherapeutics to Participate in the Stifel 2026 Virtual Immunology and Inflammation ForumArtiva Biotherapeutics, Inc. (Nasdaq: ARTV) (Artiva), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune diseases, today announced that management will participate in a fireside chat at the Stifel 2026 Virtual Immunology and Inflammation Forum on Thursday, September 24, 2026, at 10:00 am EDT.
  9. SaaSAerska Appoints Laura Sepp-Lorenzino to Scientific Advisory BoardDUBLIN and LONDON, 17 September 2026 -- Aerska, a biotechnology company bringing RNA medicines to the brain through its antibody-oligonucleotide conjugate (AOC) platform, today announces the appointment of Laura Sepp-Lorenzino to its Scientific Advisory Board, bringing more than 30 years of drug development leadership spanning nucleic acid therapies and gene editing, from early discovery through late-stage clinical development.
  10. FinanceQuince Therapeutics to Host Virtual KOL Event to Discuss the Current Treatment Landscape for PH-ILD and BOS and the Role for LAM-001 as a Potential Therapeutic Option on September 28, 2026Quince Therapeutics, Inc. (Nasdaq: QNCX), a clinical stage biopharmaceutical company focused on the development of novel, disease modifying therapies for serious, underserved diseases, today announced that it will host a virtual key opinion leader (KOL) event on Monday, September 28, 2026 from 12:30-2:00 PM ET. The event will feature PH-ILD experts Aaron B. Waxman, MD, PhD (Brigham and Women's Hospital) and Paul Yu, MD, PhD (Massachusetts General Hospital), as well as BOS expert Steven Hays, MD (UCSF Health) to discuss the current treatment landscape and unmet need for PH-ILD and BOS as well as the role for LAM-001 as a potential new therapeutic option. To register, click here.
  11. HealthcareRecludix Pharma, Inc.Recludix Pharma to Present at the Stifel 2026 Virtual Immunology and Inflammation ForumRecludix Pharma, a clinical-stage company leading the discovery and development of inhibitors of challenging targets for inflammatory disease, today announced that Nancy Whiting, Pharm.D., chief executive officer, and Ajay Nirula, M.D., Ph.D., president and head of research and development, will present an overview of the company at the Stifel 2026 Virtual Immunology and Inflammation Forum. The company’s presentation will be on Thursday, September 24, 2026, at 3:30 p.m. Eastern Time.
  12. HealthcareHemab Therapeutics Announces First Participant Dosed in Phase 1 Clinical Trial of HMB-003, an Investigational Therapy for the Management of Heavy Menstrual BleedingHeavy menstrual bleeding is reported in approximately 1 in 3 reproductive-aged women, according to the American College of Obstetricians and Gynecologists, with approximately 23 million seeking care from a healthcare professional in the U.S. last year.